Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia
NCT01614093Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Jun 2012
- Primary completion
- Jan 2014
- Countries
- 1
01
Overview
A Phase 4 trial of oxytocin nasal spray in schizophrenia, schizoaffective disorder, sponsored by University of Maryland, Baltimore. Started Jun 2012; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT01614093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01614093.